Comment évaluer le risque oncologique d'un patient souffrant de dermatomyosite [Can we predict the risk of malignancy associated with dermatomyositis?]
Details
Serval ID
serval:BIB_0FF609A29505
Type
Article: article from journal or magazin.
Publication sub-type
Case report (case report): feedback on an observation with a short commentary.
Collection
Publications
Institution
Title
Comment évaluer le risque oncologique d'un patient souffrant de dermatomyosite [Can we predict the risk of malignancy associated with dermatomyositis?]
Journal
Praxis
ISSN
1661-8157
Publication state
Published
Issued date
2003
Volume
92
Number
41
Pages
1734-9
Language
french
Notes
Publication types: Case Reports ; Comparative Study ; English Abstract ; Journal Article - Publication Status: ppublish
Abstract
Dermatomyositis (DM) and polymyositis (PM) are idiopathic inflammatory muscle diseases which remain a therapeutic challenge. The association between DM and malignancy is relatively well established while this relationship is weaker with PM. The clinical management and research for an occult malignancy as well as the follow-up of patients with DM or PM is a matter of debate. Herein we report a case of DM who, despite an extensive clinical, radiological and biological work-up developed an occult ovarian cancer 12 months after the initial diagnosis. This case report was used as support to review the actual expert recommendations for the search of an occult malignancy in presence of DM or PM.
Keywords
Adenocarcinoma, Aged, Anti-Inflammatory Agents, Anti-Inflammatory Agents, Non-Steroidal, Azathioprine, Cyclosporins, Dermatologic Agents, Dermatomyositis, Diagnosis, Differential, Female, Glucocorticoids, Humans, Immunosuppressive Agents, Mycophenolic Acid, Ovarian Neoplasms, Polymyositis, Prednisone, Risk Factors, Time Factors
Pubmed
Create date
25/01/2008 14:10
Last modification date
20/08/2019 12:36
Usage data
